{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:02:50Z","timestamp":1793854970953,"version":"4.6.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["K00 MH132569"],"award-info":[{"award-number":["K00 MH132569"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["K12 GM068524"],"award-info":[{"award-number":["K12 GM068524"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R25NS119707"],"award-info":[{"award-number":["R25NS119707"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oral cannabidiol (CBD) treatment has been suggested to alleviate severe symptoms of autism spectrum disorder (ASD). While many CBD preparations have been studied in clinical trials involving ASD, none has used purified CBD preparations or preparations approved by the U.S. Food and Drug Administration, nor have they focused on children with ASD with higher support needs. Previous studies have identified several candidate electrophysiological biomarkers of cognitive and behavioral disabilities in ASD, with emerging biomarkers including periodic (oscillatory) and aperiodic measures of neural activity. We analyzed electroencephalography (EEG) recordings from 24 boys with ASD and higher support needs (aged 7\u201314 years) from a prior double-blind, placebo-controlled, crossover Phase II Clinical Trial (NCT04517799) that investigated whether 8 weeks of daily CBD treatment (up to 20\u2009mg\/kg\/day) improved severe behavioral problems, measured at baseline, post-CBD, post-placebo, and post-washout. Using linear mixed effect models, we found that aperiodic EEG measures varied with CBD metabolite levels in blood, as evidenced by a larger aperiodic offset across the scalp and a decreased aperiodic exponent across occipital electrodes. Furthermore, CBD metabolite levels in blood had a positive association with receptive vocabulary, nonverbal intelligence and visuomotor coordination. Our data suggest that this daily CBD preparation and administration schedule produced mixed effects, with some children showing improvements in cognitive and behavioral abilities while others demonstrated limited changes. Our findings support the inclusion of aperiodic EEG measures alongside traditional oscillatory EEG measures as candidate biomarkers for tracking the variable clinical impact of purified CBD treatment in children with ASD.<\/jats:p>","DOI":"10.1038\/s41398-026-03815-y","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:05:20Z","timestamp":1769731520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cannabidiol blood metabolite levels after cannabidiol treatment are associated with broadband EEG changes and improvements in visuomotor and non-verbal cognitive abilities in boys with autism requiring higher levels of support"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8899-2109","authenticated-orcid":false,"given":"Christian","family":"Cazares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisselle","family":"Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1640-2525","authenticated-orcid":false,"given":"Bradley","family":"Voytek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"3815_CR1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD 2019 Mental Disorders Collaborators.","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137\u201350.","journal-title":"Lancet Psychiatry"},{"key":"3815_CR2","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 5th ed.. Arlington, VA: American Psychiatric Association; 2013.","edition":"5th ed."},{"key":"3815_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/WCO.0000000000000298","volume":"29","author":"KJ Varcin","year":"2016","unstructured":"Varcin KJ, Nelson CAI. A developmental neuroscience approach to the search for biomarkers in autism spectrum disorder. Curr Opin Neurol. 2016;29:123.","journal-title":"Curr Opin Neurol"},{"key":"3815_CR4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1152\/jn.00722.2015","volume":"115","author":"R Gao","year":"2016","unstructured":"Gao R. Interpreting the electrophysiological power spectrum. J Neurophysiol. 2016;115:628\u201330.","journal-title":"J Neurophysiol"},{"key":"3815_CR5","volume":"47","author":"N Schaworonkow","year":"2020","unstructured":"Schaworonkow N, Voytek B. Longitudinal changes in aperiodic and periodic activity in electrophysiological recordings in the first seven months of life. Dev Cogn Neurosci. 2020;47:100895.","journal-title":"Dev Cogn Neurosci"},{"key":"3815_CR6","volume":"16","author":"W Li","year":"2022","unstructured":"Li W. Excitation and Inhibition Imbalance in Rett Syndrome. Front Neurosci. 2022;16:825063.","journal-title":"Front Neurosci"},{"key":"3815_CR7","doi-asserted-by":"crossref","DOI":"10.1186\/s13229-021-00425-x","volume":"12","author":"CL Wilkinson","year":"2021","unstructured":"Wilkinson CL, Nelson CA. Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability. Mol Autism. 2021;12:17.","journal-title":"Mol Autism"},{"key":"3815_CR8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnint.2020.00021","volume":"14","author":"AR Levin","year":"2020","unstructured":"Levin AR, Naples AJ, Scheffler AW, Webb SJ, Shic F, Sugar CA, et al. Day-to-Day test-retest reliability of EEG Profiles in children with autism spectrum disorder and typical development. Front Integr Neurosci. 2020;14:21.","journal-title":"Front Integr Neurosci"},{"key":"3815_CR9","doi-asserted-by":"crossref","DOI":"10.1016\/j.dcn.2021.100931","volume":"48","author":"BD Ostlund","year":"2021","unstructured":"Ostlund BD, Alperin BR, Drew T, Karalunas SL. Behavioral and cognitive correlates of the aperiodic (1\/f-like) exponent of the EEG power spectrum in adolescents with and without ADHD. Dev Cogn Neurosci. 2021;48:100931.","journal-title":"Dev Cogn Neurosci"},{"key":"3815_CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s11689-019-9275-z","volume":"11","author":"KJ Roche","year":"2019","unstructured":"Roche KJ, LeBlanc JJ, Levin AR, O\u2019Leary HM, Baczewski LM, Nelson CA. Electroencephalographic spectral power as a marker of cortical function and disease severity in girls with Rett syndrome. J Neurodev Disord. 2019;11:15.","journal-title":"J Neurodev Disord"},{"key":"3815_CR11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tics.2005.08.011","volume":"9","author":"P Fries","year":"2005","unstructured":"Fries P. A mechanism for cognitive dynamics: neuronal communication through neuronal coherence. Trends Cogn Sci. 2005;9:474\u201380.","journal-title":"Trends Cogn Sci"},{"key":"3815_CR12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrn1650","volume":"6","author":"A Schnitzler","year":"2005","unstructured":"Schnitzler A, Gross J. Normal and pathological oscillatory communication in the brain. Nat Rev Neurosci. 2005;6:285\u201396.","journal-title":"Nat Rev Neurosci"},{"key":"3815_CR13","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1523\/JNEUROSCI.3737-05c.2006","volume":"26","author":"MJ Kahana","year":"2006","unstructured":"Kahana MJ. The cognitive correlates of human brain oscillations. J Neurosci. 2006;26:1669\u201372.","journal-title":"J Neurosci"},{"key":"3815_CR14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39398-7","volume":"13","author":"O Sysoeva","year":"2023","unstructured":"Sysoeva O, Maximenko V, Kuc A, Voinova V, Martynova O, Hramov A. Abnormal spectral and scale-free properties of resting-state EEG in girls with Rett syndrome. Sci Rep. 2023;13:12932.","journal-title":"Sci Rep"},{"key":"3815_CR15","doi-asserted-by":"crossref","DOI":"10.1016\/j.dcn.2022.101073","volume":"54","author":"B Ostlund","year":"2022","unstructured":"Ostlund B, Donoghue T, Anaya B, Gunther KE, Karalunas SL, Voytek B, et al. Spectral parameterization for studying neurodevelopment: How and why. Dev Cogn Neurosci. 2022;54:101073.","journal-title":"Dev Cogn Neurosci"},{"key":"3815_CR16","volume":"13","author":"WS Neo","year":"2023","unstructured":"Neo WS, Foti D, Keehn B, Kelleher B. Resting-state EEG power differences in autism spectrum disorder: a systematic review and meta-analysis. Transl Psychiatry. 2023;13:389.","journal-title":"Transl Psychiatry"},{"key":"3815_CR17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsycho.2012.11.013","volume":"92","author":"MJW Van der Molen","year":"2013","unstructured":"Van der Molen MJW, Van der Molen MW. Reduced alpha and exaggerated theta power during the resting-state EEG in fragile X syndrome. Biol Psychol. 2013;92:216\u20139.","journal-title":"Biol Psychol"},{"key":"3815_CR18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/WCO.0b013e328336eb13","volume":"23","author":"JLR Rubenstein","year":"2010","unstructured":"Rubenstein JLR. Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Curr Opin Neurol. 2010;23:118\u201323.","journal-title":"Curr Opin Neurol"},{"key":"3815_CR19","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41380-019-0426-0","volume":"24","author":"VS Sohal","year":"2019","unstructured":"Sohal VS, Rubenstein JLR. Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. Mol Psychiatry. 2019;24:1248\u201357.","journal-title":"Mol Psychiatry"},{"key":"3815_CR20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.biopsych.2015.04.016","volume":"77","author":"B Voytek","year":"2015","unstructured":"Voytek B, Knight RT. Dynamic network communication as a unifying neural basis for cognition, development, aging, and disease. Biol Psychiatry. 2015;77:1089\u201397.","journal-title":"Biol Psychiatry"},{"key":"3815_CR21","doi-asserted-by":"crossref","unstructured":"Bender A, Voytek B, Schaworonkow N. Resting-state alpha and mu rhythms change shape across development but lack diagnostic sensitivity for attention-deficit\/hyperactivity disorder and autism. J Cogn Neurosci. 2025;37:1581\u2013615.","DOI":"10.1162\/jocn_a_02323"},{"key":"3815_CR22","doi-asserted-by":"crossref","DOI":"10.1016\/j.dcn.2022.101146","volume":"57","author":"J Freschl","year":"2022","unstructured":"Freschl J, Azizi LA, Balboa L, Kaldy Z, Blaser E. The development of peak alpha frequency from infancy to adolescence and its role in visual temporal processing: A meta-analysis. Developmental Cognitive Neuroscience. 2022;57:101146.","journal-title":"Developmental Cognitive Neuroscience"},{"key":"3815_CR23","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41386-020-0697-9","volume":"45","author":"DC Javitt","year":"2020","unstructured":"Javitt DC, Siegel SJ, Spencer KM, Mathalon DH, Hong LE, Martinez A, et al. A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology. Neuropsychopharmacol. 2020;45:1411\u201322.","journal-title":"Neuropsychopharmacol"},{"key":"3815_CR24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/ejn.13645","volume":"47","author":"A Dickinson","year":"2018","unstructured":"Dickinson A, DiStefano C, Senturk D, Jeste SS. Peak alpha frequency is a neural marker of cognitive function across the autism spectrum. Eur J Neurosci. 2018;47:643\u201351.","journal-title":"Eur J Neurosci"},{"key":"3815_CR25","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s10803-011-1431-6","volume":"42","author":"L Cornew","year":"2012","unstructured":"Cornew L, Roberts TPL, Blaskey L, Edgar JC. Resting-State oscillatory activity in autism spectrum disorders. J Autism Dev Disord. 2012;42:1884\u201394.","journal-title":"J Autism Dev Disord"},{"key":"3815_CR26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10578-013-0390-x","volume":"45","author":"A Ghanizadeh","year":"2014","unstructured":"Ghanizadeh A, Sahraeizadeh A, Berk M. A Head-to-Head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial. Child Psychiatry Hum Dev. 2014;45:185\u201392.","journal-title":"Child Psychiatry Hum Dev"},{"key":"3815_CR27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00213-013-3068-y","volume":"231","author":"LC Politte","year":"2014","unstructured":"Politte LC, McDougle CJ. Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl). 2014;231:1023\u201336.","journal-title":"Psychopharmacology (Berl)"},{"key":"3815_CR28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.yebeh.2013.08.037","volume":"29","author":"BE Porter","year":"2013","unstructured":"Porter BE, Jacobson C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav. 2013;29:574\u20137.","journal-title":"Epilepsy Behav"},{"key":"3815_CR29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","volume":"15","author":"O Devinsky","year":"2016","unstructured":"Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016;15:270\u20138.","journal-title":"Lancet Neurol"},{"key":"3815_CR30","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","volume":"378","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, et al. Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome. N Engl J Med. 2018;378:1888\u201397.","journal-title":"N Engl J Med"},{"key":"3815_CR31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jns.2017.08.2623","volume":"381","author":"G Kuester","year":"2017","unstructured":"Kuester G, Vergara K, Ahumada A, Gazmuri AM. Oral cannabis extracts as a promising treatment for the core symptoms of autism spectrum disorder: Preliminary experience in Chilean patients. J Neurol Sci. 2017;381:932\u20133.","journal-title":"J Neurol Sci"},{"key":"3815_CR32","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107299","volume":"111","author":"MD Thompson","year":"2020","unstructured":"Thompson MD, Martin RC, Grayson LP, Ampah SB, Cutter G, Szaflarski JP, et al. Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy. Epilepsy Behav. 2020;111:107299.","journal-title":"Epilepsy Behav"},{"key":"3815_CR33","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10803-018-3808-2","volume":"49","author":"A Aran","year":"2019","unstructured":"Aran A, Cassuto H, Lubotzky A, Wattad N, Hazan E. Brief Report: Cannabidiol-Rich Cannabis in children with autism spectrum disorder and severe behavioral problems-A retrospective feasibility study. J Autism Dev Disord. 2019;49:1284\u20138.","journal-title":"J Autism Dev Disord"},{"key":"3815_CR34","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3389\/fphar.2018.01521","volume":"9","author":"D Barchel","year":"2019","unstructured":"Barchel D, Stolar O, De-Haan T, Ziv-Baran T, Saban N, Fuchs DO, et al. Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities. Front Pharmacol. 2019;9:1521.","journal-title":"Front Pharmacol"},{"key":"3815_CR35","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-022-02104-8","volume":"12","author":"M Hacohen","year":"2022","unstructured":"Hacohen M, Stolar OE, Berkovitch M, Elkana O, Kohn E, Hazan A, et al. Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study. Transl Psychiatry. 2022;12:375.","journal-title":"Transl Psychiatry"},{"key":"3815_CR36","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3389\/fneur.2019.01145","volume":"10","author":"P Fleury-Teixeira","year":"2019","unstructured":"Fleury-Teixeira P, Caixeta FV, Ramires da Silva LC, Brasil-Neto JP, Malcher-Lopes R. Effects of CBD-Enriched Cannabis sativa extract on autism spectrum disorder symptoms: An observational study of 18 participants undergoing compassionate use. Front Neurol. 2019;10:1145.","journal-title":"Front Neurol"},{"key":"3815_CR37","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1089\/can.2024.0062","volume":"9","author":"M Premoli","year":"2024","unstructured":"Premoli M, Carone M, Mastinu A, Maccarinelli G, Aria F, Mac Sweeney E, et al. Cannabis Sativa oil promotes social interaction and ultrasonic communication by acting on oxytocin pathway. Cannabis Cannabinoid Res. 2024;9:1514\u201323.","journal-title":"Cannabis Cannabinoid Res"},{"key":"3815_CR38","doi-asserted-by":"crossref","first-page":"14084","DOI":"10.1073\/pnas.1509795112","volume":"112","author":"D Wei","year":"2015","unstructured":"Wei D, Lee D, Cox CD, Karsten CA, Pe\u00f1agarikano O, Geschwind DH, et al. Endocannabinoid signaling mediates oxytocin-driven social reward. Proc Natl Acad Sci USA. 2015;112:14084\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3815_CR39","doi-asserted-by":"publisher","unstructured":"Trauner D, Umlauf A, Grelotti DJ, Fitzgerald R, Hannawi A, Marcotte TD, et al. Cannabidiol (CBD) treatment for severe problem behaviors in autistic boys: A randomized clinical trial. J Autism Dev Disord. 24 May 2025. https:\/\/doi.org\/10.1007\/s10803-025-06884-y.","DOI":"10.1007\/s10803-025-06884-y"},{"key":"3815_CR40","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41386-019-0333-8","volume":"44","author":"CM Pretzsch","year":"2019","unstructured":"Pretzsch CM, Freyberg J, Voinescu B, Lythgoe D, Horder J, Mendez MA, et al. Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder. Neuropsychopharmacol. 2019;44:1398\u2013405.","journal-title":"Neuropsychopharmacol"},{"key":"3815_CR41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuron.2011.09.027","volume":"72","author":"JS Isaacson","year":"2011","unstructured":"Isaacson JS, Scanziani M. How inhibition shapes cortical activity. Neuron. 2011;72:231\u201343.","journal-title":"Neuron"},{"key":"3815_CR42","doi-asserted-by":"publisher","unstructured":"Salvatore SV, Lambert PM, Benz A, Rensing NR, Wong M, Zorumski CF, et al. Periodic and aperiodic changes to cortical EEG in response to pharmacological manipulation. J Neurophysiol. 2024. 7 February 2024. https:\/\/doi.org\/10.1152\/jn.00445.2023.","DOI":"10.1152\/jn.00445.2023"},{"key":"3815_CR43","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-45922-8","volume":"15","author":"N Brake","year":"2024","unstructured":"Brake N, Duc F, Rokos A, Arseneau F, Shahiri S, Khadra A, et al. A neurophysiological basis for aperiodic EEG and the background spectral trend. Nat Commun. 2024;15:1514.","journal-title":"Nat Commun"},{"key":"3815_CR44","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1073\/pnas.1711351114","volume":"114","author":"JS Kaplan","year":"2017","unstructured":"Kaplan JS, Stella N, Catterall WA, Westenbroek RE. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proc Natl Acad Sci USA. 2017;114:11229\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3815_CR45","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.711639","volume":"15","author":"JS Kaplan","year":"2021","unstructured":"Kaplan JS, Wagner JK, Reid K, McGuinness F, Arvila S, Brooks M, et al. Cannabidiol exposure during the mouse adolescent period is without harmful behavioral effects on locomotor activity, anxiety, and spatial memory. Front Behav Neurosci. 2021;15:711639.","journal-title":"Front Behav Neurosci"},{"key":"3815_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000535726","volume":"7","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Melchert PW, Markowitz JS. Pharmacokinetic variability of oral cannabidiol and its major metabolites after short-term high-dose exposure in healthy subjects. Med Cannabis Cannabinoids. 2024;7:1\u20139.","journal-title":"Med Cannabis Cannabinoids"},{"key":"3815_CR47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40262-019-00841-6","volume":"59","author":"B Tayo","year":"2020","unstructured":"Tayo B, Taylor L, Sahebkar F, Morrison G. A Phase I, open-label, parallel-group, single-dose trial of the pharmacokinetics, safety, and tolerability of cannabidiol in subjects with mild to severe renal impairment. Clin Pharmacokinet. 2020;59:747\u201355.","journal-title":"Clin Pharmacokinet"},{"key":"3815_CR48","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","volume":"9","author":"SA Millar","year":"2018","unstructured":"Millar SA, Stone NL, Yates AS, O\u2019Sullivan SE. A systematic review on the pharmacokinetics of cannabidiol in humans. Front Pharmacol. 2018;9:1365.","journal-title":"Front Pharmacol"},{"key":"3815_CR49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/can.2015.0012","volume":"1","author":"I Ujv\u00e1ry","year":"2016","unstructured":"Ujv\u00e1ry I, Hanu\u0161 L. Human metabolites of cannabidiol: A review on their formation, biological activity, and relevance in therapy. Cannabis Cannabinoid Res. 2016;1:90\u2013101.","journal-title":"Cannabis Cannabinoid Res"},{"key":"3815_CR50","unstructured":"Brown L, Sherbenou RJ, Johnsen SK. Test of nonverbal intelligence: TONI-4. 2010."},{"key":"3815_CR51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1005596502855","volume":"30","author":"JW Bodfish","year":"2000","unstructured":"Bodfish JW, Symons FJ, Parker DE, Lewis MH. Varieties of repetitive behavior in autism: comparisons to mental retardation. J Autism Dev Disord. 2000;30:237\u201343.","journal-title":"J Autism Dev Disord"},{"key":"3815_CR52","unstructured":"Dunn LM, Dunn DM Peabody Picture Vocabulary Test\u2013Fourth Edition. 2012."},{"key":"3815_CR53","unstructured":"Martin NA, Brownell R. Expressive one-word picture vocabulary test-4 (EOWPVT-4). Academic Therapy Publications; 2011."},{"key":"3815_CR54","doi-asserted-by":"crossref","unstructured":"Beery KE, Buktenica NA, Beery NA. Beery-Buktenica Developmental Test of Visual-Motor Integration (Beery VMI). 6th Ed. Pearson; 2010.","DOI":"10.1037\/t48947-000"},{"key":"3815_CR55","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"CR Harris","year":"2020","unstructured":"Harris CR, Millman KJ, van der Walt SJ, Gommers R, Virtanen P, Cournapeau D, et al. Array programming with NumPy. Nature. 2020;585:357\u201362.","journal-title":"Nature"},{"key":"3815_CR56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17:261\u201372.","journal-title":"Nat Methods"},{"key":"3815_CR57","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.neuroimage.2017.06.030","volume":"159","author":"M Jas","year":"2017","unstructured":"Jas M, Engemann DA, Bekhti Y, Raimondo F, Gramfort A. Autoreject: Automated artifact rejection for MEG and EEG data. Neuroimage. 2017;159:417\u201329.","journal-title":"Neuroimage"},{"key":"3815_CR58","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neuroimage.2013.10.027","volume":"86","author":"A Gramfort","year":"2014","unstructured":"Gramfort A, Luessi M, Larson E, Engemann DA, Strohmeier D, Brodbeck C, et al. MNE software for processing MEG and EEG data. Neuroimage. 2014;86:446\u201360.","journal-title":"Neuroimage"},{"key":"3815_CR59","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41593-020-00744-x","volume":"23","author":"T Donoghue","year":"2020","unstructured":"Donoghue T, Haller M, Peterson EJ, Varma P, Sebastian P, Gao R, et al. Parameterizing neural power spectra into periodic and aperiodic components. Nat Neurosci. 2020;23:1655\u201365.","journal-title":"Nat Neurosci"},{"key":"3815_CR60","doi-asserted-by":"publisher","unstructured":"Skipper S, Perktold J. Statsmodels: Econometric and Modeling with Python. In Proceedings of the 9th Python in Science Conference, Austin, 28 June-3 July, 2010, 57\u201361 (2010). https:\/\/doi.org\/10.25080\/Majora-92bf1922-011.","DOI":"10.25080\/Majora-92bf1922-011"},{"key":"3815_CR61","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuroimage.2019.05.026","volume":"198","author":"L Pion-Tonachini","year":"2019","unstructured":"Pion-Tonachini L, Kreutz-Delgado K, Makeig S. ICLabel: An automated electroencephalographic independent component classifier, dataset, and website. Neuroimage. 2019;198:181\u201397.","journal-title":"Neuroimage"},{"key":"3815_CR62","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1109\/TAU.1967.1161901","volume":"15","author":"P Welch","year":"1967","unstructured":"Welch P. The use of fast Fourier transform for the estimation of power spectra: A method based on time averaging over short, modified periodograms. IEEE Trans Audio and Electroacoust. 1967;15:70\u20133.","journal-title":"IEEE Trans Audio and Electroacoust"},{"key":"3815_CR63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/1362361319874644","volume":"24","author":"B Li","year":"2020","unstructured":"Li B, Bos MG, Stockmann L, Rieffe C. Emotional functioning and the development of internalizing and externalizing problems in young boys with and without autism spectrum disorder. Autism. 2020;24:200\u201310.","journal-title":"Autism"},{"key":"3815_CR64","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/jn.00199.2017","volume":"118","author":"RA Mooney","year":"2017","unstructured":"Mooney RA, Cirillo J, Byblow WD. GABA and primary motor cortex inhibition in young and older adults: a multimodal reliability study. J Neurophysiol. 2017;118:425\u201333.","journal-title":"J Neurophysiol"},{"key":"3815_CR65","volume":"11","author":"IB Ip","year":"2021","unstructured":"Ip IB, Emir UE, Lunghi C, Parker AJ, Bridge H. GABAergic inhibition in the human visual cortex relates to eye dominance. Sci Rep. 2021;11:17022.","journal-title":"Sci Rep"},{"key":"3815_CR66","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1523\/JNEUROSCI.2041-09.2009","volume":"29","author":"JR Manning","year":"2009","unstructured":"Manning JR, Jacobs J, Fried I, Kahana MJ. Broadband shifts in local field potential power spectra are correlated with single-neuron spiking in humans. J Neurosci. 2009;29:13613\u201320.","journal-title":"J Neurosci"},{"key":"3815_CR67","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1523\/JNEUROSCI.1899-21.2022","volume":"42","author":"ZW Davis","year":"2022","unstructured":"Davis ZW, Muller L, Reynolds JH. Spontaneous Spiking Is Governed by Broadband Fluctuations. J Neurosci. 2022;42:5159\u201372.","journal-title":"J Neurosci"},{"key":"3815_CR68","volume":"54","author":"AT Hill","year":"2022","unstructured":"Hill AT, Clark GM, Bigelow FJ, Lum JAG, Enticott PG. Periodic and aperiodic neural activity displays age-dependent changes across early-to-middle childhood. Dev Cogn Neurosci. 2022;54:101076.","journal-title":"Dev Cogn Neurosci"},{"key":"3815_CR69","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.120264","volume":"277","author":"J Favaro","year":"2023","unstructured":"Favaro J, Colombo MA, Mikulan E, Sartori S, Nosadini M, Pelizza MF, et al. The maturation of aperiodic EEG activity across development reveals a progressive differentiation of wakefulness from sleep. Neuroimage. 2023;277:120264.","journal-title":"Neuroimage"},{"key":"3815_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/jn.00081.2025","volume":"134","author":"S Snipes","year":"2025","unstructured":"Snipes S. Iota oscillations (25\u201335 Hz) during wake and REM sleep in children and young adults. J Neurophysiol. 2025;134:1\u20139.","journal-title":"J Neurophysiol"},{"key":"3815_CR71","volume":"21","author":"K-W Chen","year":"2021","unstructured":"Chen K-W, Lee Y-C, Yu T-Y, Cheng L-J, Chao C-Y, Hsieh C-L. Test\u2013retest reliability and convergent validity of the test of nonverbal intelligence-fourth edition in patients with schizophrenia. BMC Psychiatry. 2021;21:39.","journal-title":"BMC Psychiatry"},{"key":"3815_CR72","doi-asserted-by":"crossref","first-page":"1038754","DOI":"10.3389\/fphar.2022.1038754","volume":"13","author":"F Pigliasco","year":"2022","unstructured":"Pigliasco F, Malaca S, Lo Faro AF, Tini A, Cangemi G, Cafaro A, et al. Cannabidiol, \u22069-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS\/MS following controlled administration in epilepsy patients. Front Pharmacol. 2022;13:1038754.","journal-title":"Front Pharmacol"},{"key":"3815_CR73","volume":"9","author":"W Bosl","year":"2011","unstructured":"Bosl W, Tierney A, Tager-Flusberg H, Nelson C. EEG complexity as a biomarker for autism spectrum disorder risk. BMC Med. 2011;9:18.","journal-title":"BMC Med"},{"key":"3815_CR74","volume":"8","author":"WJ Bosl","year":"2018","unstructured":"Bosl WJ, Tager-Flusberg H, Nelson CA. EEG Analytics for Early Detection of Autism Spectrum Disorder: A data-driven approach. Sci Rep. 2018;8:6828.","journal-title":"Sci Rep"},{"key":"3815_CR75","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/aur.2131","volume":"12","author":"CL Wilkinson","year":"2019","unstructured":"Wilkinson CL, Levin AR, Gabard-Durnam LJ, Tager-Flusberg H, Nelson CA. Reduced frontal gamma power at 24 months is associated with better expressive language in toddlers at risk for autism. Autism Res. 2019;12:1211\u201324.","journal-title":"Autism Res"},{"key":"3815_CR76","volume":"12","author":"Q Li","year":"2022","unstructured":"Li Q, Weiland RF, Konvalinka I, Mansvelder HD, Andersen TS, Smit DJA, et al. Intellectually able adults with autism spectrum disorder show typical resting-state EEG activity. Sci Rep. 2022;12:19016.","journal-title":"Sci Rep"},{"key":"3815_CR77","doi-asserted-by":"crossref","DOI":"10.1002\/dev.22271","volume":"64","author":"LC Shuffrey","year":"2022","unstructured":"Shuffrey LC, Pini N, Potter M, Springer P, Lucchini M, Rayport Y, et al. Aperiodic electrophysiological activity in preterm infants is linked to subsequent autism risk. Dev Psychobiol. 2022;64:e22271.","journal-title":"Dev Psychobiol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03815-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03815-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03815-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:04:12Z","timestamp":1771596252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03815-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3815"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-03815-y","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}